|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the FVE 10-K filed Mar 5, 2008. Other Matters. Federal and state efforts to target fraud and
abuse and violations of anti-kickback laws and physician referral laws by
Medicare and Medicaid providers have also increased. In March 2000, the
U.S. Department of Health and Human Services Office of Inspector General issued
compliance guidelines for nursing communities to assist them in developing
voluntary compliance programs to prevent fraud and abuse. The Office of Inspector General issued
compliance program guidance for hospitals in 1998 and supplemental guidance in
2005. Rules governing the privacy,
use and disclosure of individually identified health information took effect in
2003, with civil and criminal sanctions for noncompliance. Any adverse
determination concerning any of our licenses or eligibility for Medicare or
Medicaid reimbursement and the increasing costs of required compliance with
applicable federal or state regulations could adversely affect our ability to
meet our financial obligations and negatively affect our financial condition
and results of operations.
Under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, or the MPDIMA, effective January 1, 2006, Medicare beneficiaries may receive prescription drug benefits by enrolling in private health plans or managed care organizations, or if they remain in traditional Medicare, by enrolling in stand alone prescription drug plans. We believe this new law will increase the demand for pharmacy products and services by Medicare beneficiaries. We also believe that this new Medicare drug benefit may reduce the profitability of providing pharmacy products and services, as the Government implements various cost control procedures. We cannot predict the net impact of this program at this time.
A number of legislative proposals that would affect major reforms of the healthcare system are being considered during the current Presidential campaign, have been introduced in the U.S. Congress and are being considered by some state governments, such as programs for national health insurance, the option of block grants for states rather than federal matching money for certain state Medicaid services, additional policies encouraging state Medicaid programs to use home and community based long term care services rather than nursing homes, laws authorizing or directing Medicare to negotiate rate reductions for prescription drugs, additional Medicare and Medicaid enforcement procedures and federal and state cost containment measures, such as freezing Medicare or Medicaid nursing home and rehabilitation hospital payment rates at their current levels and reducing or eliminating annual Medicare or Medicaid inflation allowances or gradually reducing rates for nursing homes and rehabilitation hospitals. In connection with recent fiscal pressures on state governments and increasing costs of Medicaid funding, legislation and regulation to reduce Medicaid nursing home payment rates in some states are possible in the future. We cannot predict whether any of these legislative or regulatory proposals will be adopted or, if adopted, what effect, if any, these proposals would have on our business.
Other Matters. Federal and state efforts to target fraud and abuse and violations of anti-kickback laws and physician referral laws by Medicare and Medicaid providers have also increased. In March 2000, the U.S. Department of Health and Human Services Office of Inspector General issued compliance guidelines for nursing communities to assist them in developing voluntary compliance programs to prevent fraud and abuse. The Office of Inspector General issued compliance program guidance for hospitals in 1998 and supplemental guidance in 2005. Rules governing the privacy, use and disclosure of individually identified health information took effect in 2003, with civil and criminal sanctions for noncompliance. Any adverse determination concerning any of our licenses or eligibility for Medicare or Medicaid reimbursement and the increasing costs of required compliance with applicable federal or state regulations could adversely affect our ability to meet our financial obligations and negatively affect our financial condition and results of operations.
Under
A
This excerpt taken from the FVE DEF 14A filed Apr 23, 2007. At this time, we know of no other matters which will be brought before our annual meeting. However, if other matters properly come before our annual meeting or any postponement or adjournment thereof, and if discretionary authority to vote with respect thereto has been conferred by the enclosed proxy, the persons named in the proxy will vote the proxy in accordance with their discretion on those matters.
Newton, Massachusetts This excerpt taken from the FVE 10-K filed Mar 7, 2007. Other Matters. Federal efforts to target fraud and abuse and
violations of anti-kickback laws and physician referral laws by Medicare and
Medicaid providers have also increased. In March 2000, the U.S. Department
of Health and Human Services Office of Inspector General issued compliance
guidelines for nursing communities to assist them in developing voluntary
compliance programs to prevent fraud and abuse. The Office of Inspector General
issued compliance program guidance for hospitals in 1998 and supplemental
guidance in 2005. Rules governing the privacy, use and disclosure of
individually identified health information took effect in 2003, with civil and
criminal sanctions for noncompliance. An adverse determination concerning any
of our licenses or eligibility for Medicare or Medicaid reimbursement or the
costs of required compliance with applicable federal or state regulations could
adversely affect our ability to meet our financial obligations and negatively
affect our financial condition and results of operations.
Under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, or the MPDIMA, Medicare beneficiaries may receive prescription drug benefits effective January 1, 2006 by enrolling in private health plans or managed care organizations, or if they remain in traditional Medicare, by enrolling in stand alone prescription drug plans. We believe that this new Medicare drug benefit may increase the demand for pharmacy products and services, but may also reduce the profitability of providing those services as the Government implements various cost control procedures. We cannot predict the net impact of this program at this time. A number of legislative proposals that would affect major reforms of the healthcare system have been introduced in the U.S. Congress and many are being considered by some state governments, such as programs for national health insurance, the option of block grants for states rather than federal matching money for certain state Medicaid services, policies encouraging state Medicaid programs to use home and community based long term care services rather than nursing homes, laws authorizing or directing Medicare to negotiate rate reductions for prescription drugs, additional Medicare and Medicaid reforms and federal and state cost containment measures, such as freezing Medicare or Medicaid nursing home payment rates at their current levels and reducing or eliminating annual Medicare
9
or Medicaid inflation allowances or gradually reducing rates for nursing homes and rehabilitation hospitals. In connection with recent fiscal pressures on state governments and increasing costs of Medicaid funding, legislation and regulation to reduce Medicaid nursing home payment rates in some states are possible in the future. We cannot predict whether any of these legislative or regulatory proposals will be adopted or, if adopted, what effect, if any, these proposals would have on our business. This excerpt taken from the FVE DEF 14A filed Apr 11, 2006. OTHER MATTERS
At this time, we know of no other matters which will be brought before our annual meeting. However, if other matters properly come before our annual meeting or any postponement or adjournment thereof, and if discretionary authority to vote with respect thereto has been conferred by the enclosed proxy, the persons named in the proxy will vote the proxy in accordance with their discretion on those matters.
Newton, Massachusetts 24 This excerpt taken from the FVE 10-K filed Mar 13, 2006. Other Matters.
Federal efforts to target fraud and abuse and violations of anti-kickback laws
and physician referral laws by Medicare and Medicaid providers have also
increased. In March 2000, the U.S. Department of Health and Human Services
Office of Inspector General issued compliance guidelines for nursing
communities to assist them in developing voluntary compliance programs to
prevent fraud and abuse. Also, new rules governing the privacy, use and
disclosure of individually identified health information became final in 2001
and took effect in 2003, with civil and criminal sanctions for noncompliance.
An adverse determination concerning any of our licenses or eligibility for
Medicare or Medicaid reimbursement or the costs of required compliance with
applicable federal or state regulations could adversely affect our ability to
meet our financial obligations and negatively affect our financial condition
and results of operations.
9
Under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, Medicare beneficiaries may receive prescription drug benefits beginning January 1, 2006 by enrolling in private health plans or managed care organizations, or if they remain in traditional Medicare, by enrolling in stand alone prescription drug plans. A number of legislative proposals that would affect major reforms of the healthcare system have been introduced in the U.S. Congress and many are being considered by some state governments, such as programs for national health insurance, the option of block grants for states rather than federal matching money for certain state Medicaid services, additional Medicare and Medicaid reforms and federal and state cost containment measures, such as temporarily freezing Medicare nursing home payment rates at their current levels and reducing annual Medicare inflation allowances for nursing homes. In connection with recent fiscal pressures on state governments, legislation and regulation to reduce Medicaid nursing home payment rates in some states are possible in the future. We cannot predict whether any of these legislative or regulatory proposals will be adopted or, if adopted, what effect, if any, these proposals would have on our business.
This excerpt taken from the FVE 10-K filed Mar 29, 2005. Other Matters. Under the Medicare Prescription Drug,
Improvement and Modernization Act of 2003, Medicare beneficiaries may receive
prescription drug benefits beginning in 2006 by enrolling in private health
plans or managed care organizations, or if they remain in traditional Medicare,
by enrolling in stand alone prescription drug plans. A number of legislative
proposals that would affect major reforms of the healthcare system have been
introduced in the U.S. Congress and many are being considered by some state
governments, such as programs for national health insurance, the option of
block grants for states rather than federal matching money for certain state
Medicaid services, additional Medicare and Medicaid reforms and federal and
state cost containment measures. In connection with recent fiscal pressures on
state governments, legislation and regulation to reduce Medicaid nursing home
payment rates in some states are possible in the future. We cannot predict
whether any of these legislative or regulatory proposals will be adopted or, if
adopted, what effect, if any, these proposals would have on our business.
| EXCERPTS ON THIS PAGE:
|
| |||||||
